EMBC INVESTOR ALERT: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Hagens Berman is investigating Embecta Corp. (NASDAQ: EMBC) for alleged violations of federal securities laws, following a class action lawsuit claiming Embecta misrepresented the commercial stability of its insulin pen needle business. The lawsuit alleges the company's statements about its "stable" and "resilient" pen …